Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
01/2006
01/03/2006CA2235747C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
12/2005
12/29/2005WO2005123128A2 Methods for treating conditions associated with masp-2 dependent complement activation
12/29/2005WO2005123058A1 Antiaging agent
12/29/2005US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use
12/29/2005US20050289658 System for regulating in vivo the expression of a transgene by conditional inhibition
12/29/2005US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate
12/29/2005US20050288487 Human mast cell-expressed membrane proteins
12/29/2005US20050288368 Compositions and methods for treating and preventing necrosis
12/29/2005US20050288363 Therapeutic compositions and methods of use
12/29/2005US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent
12/29/2005US20050288325 Therapy for andropause using estrogen agonists/antagonists and testosterone
12/29/2005US20050288322 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide
12/29/2005US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/29/2005US20050287605 Caspase 3 inhibitors
12/29/2005US20050287546 Novel proteases
12/29/2005CA2847677A1 Methods for treating conditions associated with masp-2 dependent complement activation
12/29/2005CA2573144A1 Methods for treating conditions associated with masp-2 dependent complement activation
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1066033B1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
12/28/2005EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1713918A Muscle building preparation
12/28/2005CN1233404C Medicinal composition for treating amyotrophy
12/28/2005CN1233333C Process for preparing Tibetan medicines
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/22/2005WO2005120526A1 Composition for inhibiting the progress of muscular dystrophy
12/22/2005WO2005079828A3 Treatment of abnormalities of the first metatarsophalangeal joint of the foot
12/22/2005WO2004105789A8 Grf analog compositions and their use
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282880 Novel 1H-indazole compounds
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282865 Neurotrophic factor production promoter
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050281846 Local administration of a botulinum toxin, especially botulinum toxin type A, to an injured muscle to facilitate healing of injured biceps, knee or shin muscles.
12/22/2005US20050281788 Compositions comprising muscle progenitor cells and uses thereof
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1278730B1 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005CN1232532C Fibroblast growth factor-2 analogue, producing process and application thereof
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005US20050276820 structural modification alters the biological persistence, preferably the biological half-life
12/14/2005EP1605040A1 Monocyte-origin multipotent cell momc
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1604674A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
12/14/2005EP1604671A1 Muscle-building agent and preventive or remedy for muscle weakening
12/14/2005EP1604646A1 Viscous compositions containing carbon dioxide
12/14/2005EP1604645A1 Viscous compositions containing carbon dioxide
12/14/2005EP1603945A2 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
12/14/2005EP1603582A1 Petasite, petasite extract and/or petasite extract fractions thereof for acute treatment of pathological conditions
12/14/2005EP1603580A1 Composition for administration of iron for the treatment of restless legs syndrome
12/14/2005EP1603576A1 Use of adenosine receptor agonists in therapy
12/14/2005EP1603532A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
12/14/2005EP1330428B1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride
12/14/2005EP1274430B1 Cabergoline for the treatment of fibromyalgia and chronic fatigue syndrome
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708313A Organic extract for Japonicum Thunb and application thereof
12/14/2005CN1708311A Remedy for fibromyalgia
12/14/2005CN1706838A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/08/2005WO2005116194A1 Method of culturing myoblst or myoblast-like cell for forming myofiber in vitro
12/08/2005WO2005116191A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor
12/08/2005WO2002057256A9 Piperazinylcarbonylquinolines and -isoquinolines
12/08/2005US20050272936 Imidazolium cxcr3 inhibitors
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272767 Method for treating myolytic disease and method for screening antimyolytic agent
12/08/2005US20050272761 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/08/2005US20050272148 Method of collecting placental stem cells
12/08/2005US20050272028 Myostatin and mimetics thereof
12/07/2005EP1602666A1 Novel protein and its dna
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602656A1 Pyrazole derivatives having affinity for cb1 and/or cb2 receptors
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601363A2 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof
12/07/2005EP1496917B1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
12/07/2005EP1303269B1 Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
12/07/2005EP1216257B1 Compounds for the treatment of ischemia
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 233